Free Trial

Beneficient (BENF) Competitors

Beneficient logo
$0.31 +0.01 (+2.13%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$0.30 -0.01 (-2.56%)
As of 08/15/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BENF vs. SLNH, MIGI, CARV, SHFS, SOS, MEGL, NRBO, PWM, SNTG, and OCTO

Should you be buying Beneficient stock or one of its competitors? The main competitors of Beneficient include Soluna (SLNH), Mawson Infrastructure Group (MIGI), Carver Bancorp (CARV), SHF (SHFS), SOS (SOS), Magic Empire Global (MEGL), NeuroBo Pharmaceuticals (NRBO), Prestige Wealth (PWM), Sentage (SNTG), and Eightco (OCTO). These companies are all part of the "banking" industry.

Beneficient vs. Its Competitors

Soluna (NASDAQ:SLNH) and Beneficient (NASDAQ:BENF) are both small-cap banking companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability and valuation.

Soluna has a beta of 3.68, indicating that its stock price is 268% more volatile than the S&P 500. Comparatively, Beneficient has a beta of -0.55, indicating that its stock price is 155% less volatile than the S&P 500.

Beneficient has a net margin of 0.00% compared to Soluna's net margin of -222.81%. Beneficient's return on equity of 0.00% beat Soluna's return on equity.

Company Net Margins Return on Equity Return on Assets
Soluna-222.81% -175.99% -67.69%
Beneficient N/A N/A N/A

In the previous week, Soluna had 4 more articles in the media than Beneficient. MarketBeat recorded 7 mentions for Soluna and 3 mentions for Beneficient. Soluna's average media sentiment score of 1.06 beat Beneficient's score of 0.29 indicating that Soluna is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Soluna
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Beneficient
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Beneficient has lower revenue, but higher earnings than Soluna.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Soluna$38.02M0.25-$63.33M-$11.29-0.05
Beneficient-$20.08M-0.13N/AN/AN/A

23.2% of Soluna shares are owned by institutional investors. Comparatively, 90.6% of Beneficient shares are owned by institutional investors. 23.7% of Soluna shares are owned by insiders. Comparatively, 13.7% of Beneficient shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Soluna
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Beneficient
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Soluna beats Beneficient on 7 of the 11 factors compared between the two stocks.

Get Beneficient News Delivered to You Automatically

Sign up to receive the latest news and ratings for BENF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BENF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BENF vs. The Competition

MetricBeneficientFIN IndustryFinance SectorNASDAQ Exchange
Market Cap$2.70M$7.74B$12.40B$9.80B
Dividend YieldN/A4.79%5.56%4.13%
P/E RatioN/A17.3819.5625.06
Price / Sales-0.136.8426.0697.37
Price / CashN/A24.3921.7758.67
Price / BookN/A4.362.286.18
Net IncomeN/A$311.03M$1.00B$265.11M
7 Day Performance8.71%0.97%1.21%4.22%
1 Month Performance-0.70%2.73%0.82%0.77%
1 Year Performance-86.32%28.99%543.13%24.69%

Beneficient Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BENF
Beneficient
0.9014 of 5 stars
$0.31
+2.1%
N/A-86.3%$2.70M-$20.08M0.0080Upcoming Earnings
Short Interest ↑
SLNH
Soluna
1.9065 of 5 stars
$0.52
+16.2%
N/A-88.7%$9.52M$38.02M-0.0560News Coverage
Earnings Report
Short Interest ↓
Gap Up
High Trading Volume
MIGI
Mawson Infrastructure Group
0.6845 of 5 stars
$0.46
+4.6%
N/A-68.0%$9.11M$59.26M-0.3240Earnings Report
Upcoming Earnings
Short Interest ↓
Gap Down
CARV
Carver Bancorp
0.107 of 5 stars
$1.72
+5.5%
N/A-10.0%$8.72M$37.37M-0.65110News Coverage
Positive News
Earnings Report
Short Interest ↑
SHFS
SHF
1.4754 of 5 stars
$2.59
-1.9%
N/A-79.5%$7.20M$15.24M0.763Earnings Report
Short Interest ↓
Gap Up
SOS
SOS
N/A$2.04
-4.7%
N/A-83.3%$6.39M$231.42M0.00170High Trading Volume
MEGL
Magic Empire Global
0.5539 of 5 stars
$1.38
-0.6%
N/A-20.8%$5.60M$1.65M0.008Positive News
Short Interest ↑
NRBO
NeuroBo Pharmaceuticals
N/A$0.64
+1.3%
N/A-82.5%$5.50MN/A0.0010Gap Up
PWM
Prestige Wealth
0.8256 of 5 stars
$0.37
+0.7%
N/A-47.2%$5.34M$640K0.004News Coverage
Positive News
Short Interest ↓
Gap Down
SNTG
Sentage
1.8333 of 5 stars
$1.73
+1.2%
N/A-16.8%$4.86M$110K0.0020Positive News
Short Interest ↓
OCTO
Eightco
0.6803 of 5 stars
$1.52
+3.4%
N/AN/A$4.62M$39.62M0.0035News Coverage
Positive News
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:BENF) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners